Concepedia

Steven C. Griffen

SC

Statistics

Publications

38

Citations

5.4K

H-Index

31

Active since

1987

Affiliations

University of California, Davis(Current)

Bristol-Myers Squibb (United States)

Western Human Nutrition Research Center

University of California, San Francisco

University of California Davis Medical Center

Steven C. Griffen is an author at University of California, Davis specializing in medicine, diabetes, and metabolism.

Top concepts

Publications per year

1987–2019

38

Publications

38

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

Kimber L. Stanhope, Jean Marc Schwarz, Nancy L. Keim et al. · Journal of Clinical Investigation · 2009 · 1.7K citations · Full text

Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State

Sridevi Devaraj, Mohan R. Dasu, Jason Rockwood et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 367 citations · Full text

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

, , +9

Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes

Ralph A. DeFronzo, Marcus Hompesch, Sreeneeranj Kasichayanula et al. · Diabetes Care · 2013 · 281 citations · Full text

Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Robert R. Henry, Julio Rosenstock, Steven V. Edelman et al. · Diabetes Care · 2014 · 237 citations

1–5 of 38